Table: Wakamoto Pharm - 9-MTH parent results

Wakamoto Pharmaceutical

05/02/2024 06:00

Feb 5 (Reuters)- 
             Wakamoto Pharmaceutical Co Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to  
                Dec 31, 2023        Dec 31, 2022      Mar 31, 2024 
                   LATEST             YEAR-AGO           LATEST    
                   RESULTS             RESULTS          FORECAST   
  Sales             5.59                6.27              7.80     
                 (-10.9 pct)         (+0.0 pct)        (-9.9 pct)  
  Operating     loss 259 mln           33 mln         loss 120 mln 
  Recurring     loss 225 mln           128 mln        loss 80 mln  
  Net           loss 205 mln           110 mln        loss 20 mln  
                                     (-47.5 pct)                   
  EPS           loss 5.92 yen         3.18 yen       loss 0.58 yen 
  Ann Div                             3.00 yen                     
  -Q2 div            NIL                 NIL                       
  -Q4 div                             3.00 yen                     
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T